Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Delamanid

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Delamanid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,692Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Getting patented meds on NLEM list an uphill battle says committee member
    Getting patented meds on NLEM list an uphill battle says committee member

    15 Sep 2022

    // Teena Thacker ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/getting-patented-meds-on-nlem-list-an-uphill-battle-says-committee-member/articleshow/94213010.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    Teena Thacker ECONOMIC TIMES
    15 Sep 2022
    Share Share
    Diabetes, patented TB, HIV drugs enter essential list
    Diabetes, patented TB, HIV drugs enter essential list

    13 Sep 2022

    // Teena Thacker ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/diabetes-patented-tb-hiv-drugs-enter-essential-list/articleshow/94185393.cms

    Teena Thacker ECONOMICTIMES
    13 Sep 2022
    Share Share
    Otsuka Announces Approval in EU of Pediatric, 25 mg Dispersible-Tablet
    Otsuka Announces Approval in EU of Pediatric, 25 mg Dispersible-Tablet

    06 Oct 2021

    // JIHO

    https://pj.jiho.jp/article/245342

    JIHO
    06 Oct 2021
    Share Share
    Deltyba® (delamanid) approved in Russian Federation for treatment of pulmonary
    Deltyba® (delamanid) approved in Russian Federation for treatment of pulmonary

    25 May 2020

    // PRESS RELEASE

    https://www.otsuka.co.jp/en/company/newsreleases/2020/20200525_1.html

    PRESS RELEASE
    25 May 2020
    Share Share
    Delamanid, Bedaquiline-based therapy to be boosted to tackle MDR TB
    Delamanid, Bedaquiline-based therapy to be boosted to tackle MDR TB

    08 Feb 2019

    // PHARMA BIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=114048&sid=1

    PHARMA BIZ
    08 Feb 2019
    Share Share
    Johnson and Johnson asked to cut down price of new TB drug
    Johnson and Johnson asked to cut down price of new TB drug

    23 Oct 2018

    // Divya Rajagopal ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/johnson-and-johnson-asked-to-cut-down-price-of-new-tb-drug/articleshow/66334298.cms

    Divya Rajagopal ECONOMIC TIMES
    23 Oct 2018
    Share Share